Effect of NSAIDs on risk of Alzheimer's disease

doi:10.1136/bmj.327.7417.752

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ comment articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Conclusions on NSAIDs and Alzheimer's disease were overstated

David Price, associate professor of family medicine and psychiatry (david.price@kp.org)

University of Colorado Health Sciences Center, 2550 South Parker Road, Suite 300, Aurora, CO 80014, USA

EDITOR–Etminan et al present a systematic review and meta-analysis on the use of nonsteroidal anti-inflammatory drugs (NSAIDs) and the risk of developing subsequent Alzheimer's disease.1 The trials included in the review were observational studies (six cohort and three case-control). While theoretical …